Stralem & Co’s Colgate-Palmolive CL Stock Holding History

Stralem & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,700	Closed	-$941K	–	48
2017 Q2	$941K	Hold	12,700	–	–	0.11%	44
2017 Q1	$930K	Hold	12,700	–	–	0.11%	44
2016 Q4	$831K	Hold	12,700	–	–	0.1%	44
2016 Q3	$942K	Buy	12,700 +500	+4%	+$37K	0.11%	42
2016 Q2	$893K	Hold	12,200	–	–	0.1%	45
2016 Q1	$862K	Sell	12,200 -4,800	-28%	-$319K	0.09%	43
2015 Q4	$1.13M	Hold	17,000	–	–	0.11%	43
2015 Q3	$1.08M	Sell	17,000 -100	-0.6%	-$6.53K	0.09%	43
2015 Q2	$1.12M	Hold	17,100	–	–	0.08%	42
2015 Q1	$1.19M	Sell	17,100 -300	-2%	-$20.7K	0.07%	43
2014 Q4	$1.2M	Hold	17,400	–	–	0.06%	41
2014 Q3	$1.14M	Hold	17,400	–	–	0.05%	40
2014 Q2	$1.19M	Hold	17,400	–	–	0.04%	39
2014 Q1	$1.13M	Sell	17,400 -400	-2%	-$25.2K	0.04%	42
2013 Q4	$1.16M	Hold	17,800	–	–	0.03%	42
2013 Q3	$1.06M	Hold	17,800	–	–	0.03%	42
2013 Q2	$1.02M	Buy	+17,800	New	+$1.06M	0.03%	42

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Stralem & Co's CL Position: Q3 2017 in Review

Stralem & Co sold out of Colgate-Palmolive (CL) in Q3 2017, closing a stake of 12,700 shares — an estimated $941K sold.

Stralem & Co first reported a position in CL in Q2 2013 and held it in 17 quarters. The position peaked at $1.2M in Q4 2014. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

Stralem & Co reported no remaining Colgate-Palmolive position as of Q3 2017 after selling out during the quarter.
Stralem & Co sold 12,700 Colgate-Palmolive shares in Q3 2017, an estimated $941K.
Stralem & Co first reported a position in Colgate-Palmolive in Q2 2013 and held it in 17 quarters.
Stralem & Co's Colgate-Palmolive position peaked at $1.2M in Q4 2014.
1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on Stralem & Co's 13F filing for Q3 2017, filed 16 Oct 2017.